thrombosis
Conditions
Interventions
experimental group 1:Anticoagulation with Fondaparinux
experimental group 2:Low molecular weight heparin anticoagulation
experimental group 3:Traditional Chinese Medicine Decoction - Modified Buyang Huanwu Decoction
control group:No anticoagulation
Sponsors
Sun Simiao Hospital, Beijing University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. The patient needs to indwell a catheter through the internal jugular vein or subclavian meridian due to disease (either PICC or infusion port can be used); 2. Expected bed rest time >= 3days; 3. Expected survival > 3 months; 4. Aged >= 18 years; 5. Patients without mental illness; 6. Understand and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. The puncture site has received radiotherapy or severe vascular deformation; 2. Puncture catheter path vein through the vascular surgery site; 3. Patients who have installed cardiac pacemakers or have undergone cardiac surgery; 4. Patients with a history of acute thrombosis or subclavian vein and superior vena cava occlusion; 5. Patients with contraindications to the drugs used in the research; 6. Patients who are participating in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Venous thromboembolism; | — |
Countries
China
Contacts
Public ContactWen Jiansheng
Sun Simiao Hospital of Beijing University of Traditional Chinese Medicine
Outcome results
None listed